ZoomRx's Ferma Named One of 2023's Most Innovative Life Sciences Advancements

December 15, 2023 04:15 AM AEDT | By EIN Presswire
 ZoomRx's Ferma Named One of 2023's Most Innovative Life Sciences Advancements
Image source: EIN Presswire

CAMBRIDGE, MA, UNITED STATES, December 14, 2023 /EINPresswire.com/ -- ZoomRx, a pioneering force in technological solutions for the life sciences sector, is proud to announce its recent recognition in PM360’s 12th Annual Innovations Issue. ZoomRx has been awarded for its groundbreaking innovations in the life sciences and healthcare industries, particularly through its state-of-the-art generative AI technology, Ferma.

Over the course of the year, the Ferma platform has served as an incubator and innovation hub for life sciences companies to develop their own custom AI solutions. By acting as a vessel for custom generative AI applications, Ferma has significantly advanced the way life sciences professionals access, analyze, and leverage unstructured and structured data.

"Ferma is continuously evolving our AI solutions to help ensure our life sciences clients stay ahead of the curve. This PM360 distinction serves as a recognition of the people and expertise behind our innovative technology, and I couldn’t be more excited for our team. Using this distinction as momentum, we look forward to continuing our pursuit of developing breakthrough offerings for more efficient and effective operations," said Andrew Yukawa, Product Manager.

In its 12th year, PM360’s Innovations Issue is published each December. This issue was established as the industry’s first-ever guide to the year’s most innovative advancements and has since become a premier resource. This year, the issue expanded to include 13 categories: Artificial Intelligence; Clinical Trials; Consumer Tech and Wellness; Core Business Processes; Data and Cybersecurity; Employee Acquisition, Development, and Programs; Health Technology Non-Consumer; Life Sciences; Marketing Technology or Services; Metaverse; Payers/Insurance Companies; Startups; and Telehealth/Telemedicine.

In total, 56 innovations were selected by PM360’s editorial staff for inclusion in the issue out of hundreds of submissions.

“We know the importance of innovation, which is why we expanded this issue to include the most fascinating and groundbreaking achievements being made in all areas of life sciences, healthcare, and marketing,” says Anna Stashower, CEO, Publisher, and Editor-in-Chief of PM360. “The innovations we selected are changing how our industry operates to create better ways to develop treatments, run companies, educate physicians, improve diagnosis, and much more to ultimately find better ways to serve patients.”

###

About ZoomRx

ZoomRx is a leading life sciences solutions provider relied on by over 15 of the top 20 global biopharma firms. Our technology and expertise enable our clients to better serve healthcare providers, patients, and other key stakeholders.

Through visionary creativity, proprietary technology, and an expert consulting team, ZoomRx provides valuable solutions that enable clients to optimize the effectiveness of their operations, drive growth, and create lifechanging and lifesaving therapies.

For more information, visit www.zoomrx.com or www.ferma.ai and follow us on LinkedIn.

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.

The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.

By providing a full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.

Andrew Yukawa
ZoomRx
[email protected]
Visit us on social media:
LinkedIn


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.